191. Per Med. 2018 May 1;15(3):153-155. doi: 10.2217/pme-2017-0083. Epub 2018 May 10.Clinical criteria revision for hereditary lobular breast cancer associated withE-cadherin germline mutations.Corso G(1), De Scalzi A(1), Feroce I(2), Veronesi P(1)(3), Bonanni B(2),Galimberti V(1).Author information: (1)Division of Breast Cancer Surgery, European Institute of Oncology, Via G.Ripamonti 435, Milan 20141, Italy.(2)Division of Cancer Prevention & Genetics, European Institute of Oncology, Via G.Ripamonti 435, Milan 20141, Italy.(3)School of Medicine, University of Milan, Milan 20122, Italy.DOI: 10.2217/pme-2017-0083 PMID: 29745790 